Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018)-Reference-Cited by-同舟云学术

Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018)

Published:2019-08-01 Issue:15 Volume:58 Page:2159-2166
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Kawano Noriaki¹,Yoshida Noriaki²³,Kawano Sayaka¹,Arakawa Fumiko²,Miyoshi Hiroaki²,Yamada Kyohei²,Nakashima Kazutaka²,Yoshida Shuro¹,Kuriyama Takuro¹,Tochigi Taro¹,Nakaike Takashi¹,Shimokawa Tomonori¹,Yamashita Kiyoshi¹,Marutsuka Kousuke⁴,Mashiba Koichi¹,Kikuchi Ikuo¹,Ohshima Koichi²

Affiliation:

1. Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan

2. Department of Pathology, Kurume University, Japan

3. Department of Clinical Studies, Radiation Effects Research Foundation, Japan

4. Department of Pathology, Miyazaki Prefectural Miyazaki Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/58/15/58_2513-18/_pdf

Reference36 articles.

1. 1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50: 481-492, 1977.

2. 2. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 81: 25342537, 1984.

3. 3. Tajima K, Kuroishi T. Estimation of rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan. Jpn J Clin Oncol 15: 423-430, 1985.

4. 4. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 79: 428-437, 1991.

5. 5. Yamada Y, Tomonaga M, Fukuda H, et al. A new G-CSF supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 113: 375-382, 2001.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical impact of the ratio of C-reactive protein to albumin (CAR) in patients with acute- and lymphoma-type adult T-cell leukemia-lymphoma (ATL);Journal of Clinical and Experimental Hematopathology;2023

2. Mogamulizumab for post-transplant relapse of adult T-cell leukemia/lymphoma: a case study;International Journal of Hematology;2022-09-09

3. Correlation of CCR4 aberrations with clinical features and immunophenotypes of neoplastic cells in patients with adult T-cell leukemia/lymphoma treated at our institution;Tenri Medical Bulletin;2021-12-25

4. Clinical Applications of Genomic Alterations in ATLL: Predictive Markers and Therapeutic Targets;Cancers;2021-04-09

5. Comprehensive genomic analysis identifying heterogeneity in peripheral T‐cell lymphoma;Cancer Science;2021-02-25